Skip to content
Clinical Trials – home

Carbetocin: A Comprehensive Guide for Patients

0 / 2
trials open to patients / all trials
5+
Countries

In short

Carbetocin, a synthetic analogue of oxytocin, has been the subject of numerous clinical trials investigating its efficacy in preventing postpartum hemorrhage and other medical conditions. This article explores the various studies conducted on carbetocin, focusing on its use in obstetrics, particularly during cesarean deliveries, as well as its potential applications in other areas of medicine.

At a glance

Main Focus
Prevention of postpartum hemorrhage during cesarean deliveries
Dose Range Studied
2 mcg to 140 mcg
Administration Method
Intravenous injection over 1 minute following delivery of the fetal head
Primary Outcomes
Uterine tone, need for additional uterotonics, estimated blood loss
Secondary Outcomes
Side effects (hypotension, tachycardia, nausea, etc.), long-term safety and efficacy
Special Populations
Women with BMI ≥ 40 kg/m2, twin pregnancies, laboring women
Other Applications
Treatment of hyperphagia in Prader-Willi Syndrome (nasal spray formulation)
Cardiac Effects
Studied for potential impact on myocardial repolarization dynamics

What is Carbetocin?

Carbetocin is a medication used primarily in obstetrics, the branch of medicine dealing with childbirth. It is a synthetic analogue of oxytocin, which means it's an artificially created version of a hormone naturally produced in the body. Carbetocin is also known by other names such as Duratocin, Pabal, and ACP-101.

Uses of Carbetocin

Carbetocin is primarily used to prevent and treat a condition called postpartum hemorrhage (PPH). PPH is excessive bleeding after childbirth and is a major cause of maternal death worldwide. The main uses of carbetocin include:

  • Preventing uterine atony (poor muscle tone of the uterus) after cesarean section deliveries
  • Managing the third stage of labor (the period after the baby is born until the placenta is delivered) in women at low risk of PPH
  • Promoting uterine contraction after vaginal or cesarean deliveries

In addition to its use in obstetrics, carbetocin is also being studied for other conditions. For example, it's being researched as a potential treatment for hyperphagia (excessive hunger) in people with Prader-Willi Syndrome, a rare genetic disorder.

How Carbetocin Works

Carbetocin works in a similar way to oxytocin, a hormone naturally produced in the body. It causes the uterus to contract, which is crucial after childbirth to prevent excessive bleeding. The key difference is that carbetocin lasts 4 to 7 times longer than oxytocin in the body, which means it can provide a more sustained effect.

Administration and Dosage

Carbetocin is typically administered in the following ways:

  • As an intravenous (IV) injection, usually given over 1 minute immediately after the delivery of the baby
  • As a nasal spray in some research settings

The dosage of carbetocin can vary. While the Society of Obstetricians and Gynecologists of Canada (SOGC) has recommended a single 100 microgram (mcg) dose, research is ongoing to determine if lower doses might be equally effective with fewer side effects.

Effectiveness

Studies have shown that carbetocin is effective in preventing postpartum hemorrhage. It appears to be at least as effective as oxytocin, the standard treatment, and may have some advantages:

  • Longer-lasting effect, reducing the need for additional medications
  • Potentially less blood loss compared to other treatments
  • May be particularly beneficial in certain high-risk groups, such as women with twin pregnancies or obesity

Side Effects

Like all medications, carbetocin can have side effects. Common side effects may include:

  • Low blood pressure (hypotension)
  • Rapid heart rate (tachycardia)
  • Nausea and vomiting
  • Headache
  • Flushing (reddening of the skin)

In rare cases, more serious side effects like abnormal heart rhythms may occur. Researchers are studying the effects of carbetocin on heart function to ensure its safety.

Ongoing Research

Carbetocin continues to be the subject of ongoing research. Some areas of current study include:

  • Determining the optimal dose for different patient groups, such as women with obesity or twin pregnancies
  • Comparing different routes of administration, such as nasal sprays
  • Investigating its potential use in other conditions, like Prader-Willi Syndrome
  • Studying its long-term safety and effectiveness

As research continues, our understanding of carbetocin and its uses may expand, potentially leading to improved treatments for postpartum hemorrhage and other conditions.

Questions people often ask

Conditions where Carbetocin is being studied

Each condition opens its own overview and trial list

Trials with Carbetocin

Recruiting trials first

See all 2 →
Quick filters
  • Participants:All ages
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.